ING Group’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-22,049
| Closed | -$4.05M | – | 611 |
|
|
2021
Q2 | $4.05M | Buy |
22,049
+7,493
| +51% | +$1.29M | 0.06% | 188 |
|
|
2021
Q1 | $2.23M | Buy |
14,556
+40
| +0.3% | +$6.19K | 0.05% | 229 |
|
|
2020
Q4 | $2.27M | Buy |
14,516
+9,665
| +199% | +$1.24M | 0.05% | 224 |
|
|
2020
Q3 | $555K | Buy |
4,851
+2,983
| +160% | +$322K | 0.02% | 282 |
|
|
2020
Q2 | $210K | Buy |
+1,868
| New | +$198K | 0.01% | 271 |
|
|
2020
Q1 | – | Sell |
-15,179
| Closed | -$1.64M | – | 516 |
|
|
2019
Q4 | $1.64M | Buy |
15,179
+1,186
| +8% | +$127K | 0.05% | 230 |
|
|
2019
Q3 | $1.37M | Sell |
13,993
-136,362
| -91% | -$15.4M | 0.03% | 258 |
|
|
2019
Q2 | $19.7M | Buy |
+150,355
| New | +$19.4M | 0.34% | 58 |
|
|
2019
Q1 | – | Sell |
-26,840
| Closed | -$2.61M | – | 850 |
|
|
2018
Q4 | $2.61M | Buy |
26,840
+5,416
| +25% | +$640K | 0.06% | 198 |
|
|
2018
Q3 | $2.98M | Buy |
+21,424
| New | +$2.69M | 0.05% | 215 |
|
|
2018
Q2 | – | Sell |
-19,333
| Closed | -$2.15M | – | 876 |
|
|
2018
Q1 | $2.15M | Sell |
19,333
-33,994
| -64% | -$4.06M | 0.04% | 206 |
|
|
2017
Q4 | $6.38M | Buy |
53,327
+3,445
| +7% | +$420K | 0.11% | 101 |
|
|
2017
Q3 | $7M | Buy |
49,882
+40,410
| +427% | +$5.49M | 0.13% | 115 |
|
|
2017
Q2 | $1.15M | Buy |
9,472
+1,215
| +15% | +$141K | 0.02% | 298 |
|
|
2017
Q1 | $1M | Buy |
+8,257
| New | +$1.06M | 0.02% | 339 |
|
|
2016
Q1 | – | Sell |
-86,239
| Closed | -$16.4M | – | 713 |
|
|
2015
Q4 | $16.4M | Buy |
86,239
+3,997
| +5% | +$698K | 0.1% | 184 |
|
|
2015
Q3 | $12.8M | Buy |
+82,242
| New | +$15M | 0.09% | 179 |
|
|
2015
Q2 | – | Sell |
-35,731
| Closed | -$6.19M | – | 761 |
|
|
2015
Q1 | $6.19M | Buy |
35,731
+171
| +0.5% | +$31K | 0.03% | 358 |
|
|
2014
Q4 | $6.58M | Buy |
35,560
+7,000
| +25% | +$1.3M | 0.03% | 346 |
|
|
2014
Q3 | $4.74M | Sell |
28,560
-382
| -1% | -$62.7K | 0.03% | 364 |
|
|
2014
Q2 | $4.52M | Sell |
28,942
-4,356
| -13% | -$688K | 0.02% | 372 |
|
|
2014
Q1 | $5.08M | Buy |
33,298
+3,332
| +11% | +$530K | 0.03% | 364 |
|
|
2013
Q4 | $3.98M | Buy |
29,966
+971
| +3% | +$117K | 0.02% | 388 |
|
|
2013
Q3 | $3.36M | Sell |
28,995
-14,439
| -33% | -$1.58M | 0.02% | 436 |
|
|
2013
Q2 | $4.01M | Buy |
+43,434
| New | +$4.19M | 0.02% | 389 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM